Clinical characteristics of acanthamoeba keratitis infections in 28 states, 2008 to 2011

Cornea

Volumn 33, Issue 2, 2014, Pages 161-168

  Ross, Jonathan ^a   Roy, Sharon L ^a   Mathers, William D ^b   Ritterband, David C ^c   Yoder, Jonathan S ^a   Ayers, Tracy ^a   Shah, Rupa D ^d   Samper, Monika E ^e   Shih, Carolyn Y ^f   Schmitz, Ann ^g   Brown, Allison C ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NEW YORK EYE AND EAR INFIRMARY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OREGON PUBLIC HEALTH DIVISION   (United States)

^f NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^g FLORIDA DEPARTMENT OF HEALTH   (United States)

Author keywords

Acanthamoeba; Diagnosis; Risk factors

Indexed keywords

ANTIAMEBIC AGENT; STEROID;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ADULT; BLURRED VISION; CLINICAL FEATURE; CONTACT LENS; EPIPHORA; EYE DISCHARGE; EYE PAIN; EYE REDNESS; HUMAN; HYPOPYON; KERATOPATHY; KERATOPLASTY; MAJOR CLINICAL STUDY; PHOTOPHOBIA; PRIORITY JOURNAL; REVIEW; SCLERITIS; VISUAL ACUITY;

ACANTHAMOEBA KERATITIS; ADULT; AMEBICIDES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; VISUAL ACUITY; YOUNG ADULT;

EID: 84892993815     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000014     Document Type: Review

References (39)

1. Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989;107:331-336.
2. Ibrahim YW, Boase DL, Cree IA. Factors affecting the epidemiology of Acanthamoeba keratitis. Ophthalmic Epidemiol. 2007;14:53-60.
3. Radford CF, Minassian DC, Dart JK. Acanthamoeba keratitis in England and Wales: Incidence, outcome, and risk factors. Br J Ophthalmol. 2002; 86:536-542.
4. Thebpatiphat N, Hammersmith KM, Rocha FN, et al. Acanthamoeba keratitis: A parasite on the rise. Cornea. 2007;26:701-706.
5. Verani JR, Lorick SA, Yoder JS, et al. National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis. 2009;15:1236-1242.
6. Sharma S, Garg P, Rao GN. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol. 2000;84:1103-1108.
7. Srinivasan M, Burman S, George C, et al. Non-contact lens related Acanthamoeba keratitis at a tertiary eye care center in south India: Implications for eye care programs in the region. Med Sci Monit. 2003;9:CR125-CR129.
8. Radford CF, Lehmann OJ, Dart JK. Acanthamoeba keratitis: Multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group. Br J Ophthalmol. 1998;82:1387-1392.
9. Tanhehco T, Colby K. The clinical experience of Acanthamoeba keratitis at a tertiary care eye hospital. Cornea. 2010;29:1005-1010.
10. Awwad ST, Petroll WM, McCulley JP, et al. Updates in Acanthamoeba keratitis. Eye Contact Lens. 2007;33:1-8.
11. Mathers WD, Sutphin JE, Folberg R, et al. Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol. 1996;121:129-142.
12. Kovacevic D, Misljenovic T, Misljenovic N, et al. Acanthamoeba keratitis-importance of the early diagnosis. Coll Antropol. 2008;32 (suppl 2):221-224.
13. Tu EY, Joslin CE, Sugar J, et al. The relative value of confocal microscopy and superficial corneal scrapings in the diagnosis of Acanthamoeba keratitis. Cornea. 2008;27:764-772.
14. Boggild AK, Martin DS, Lee TY, et al. Laboratory diagnosis of amoebic keratitis: Comparison of four diagnostic methods for different types of clinical specimens. J Clin Microbiol. 2009;47:1314-1318.
15. Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: Diagnosis and treatment update 2009. Am J Ophthalmol. 2009;148:487-499.e2.
16. Hau SC, Dart JK, Vesaluoma M, et al. Diagnostic accuracy of microbial keratitis with in vivo scanning laser confocal microscopy. Br J Ophthalmol. 2010;94:982-987.
17. Claerhout I, Goegebuer A, Van Den Broecke C, et al. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol. 2004;242:648-653.
18. Qian Y, Meisler DM, Langston RH, et al. Clinical experience with Acanthamoeba keratitis at the cole eye institute, 1999-2008. Cornea. 2010;29:1016-1021.
19. Tu EY, Joslin CE, Sugar J, et al. Prognostic factors affecting visual outcome in Acanthamoeba keratitis. Ophthalmology. 2008;115:1998-2003.
20. Coulon C, Collignon A, McDonnell G, et al. Resistance of Acanthamoeba cysts to disinfection treatments used in health care settings. J Clin Microbiol. 2010;48:2689-2697.
21. Miedziak AI, Miller MR, Rapuano CJ, et al. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 1999;106: 1166-1170; discussion 1171.
22. Oldenburg CE, Acharya NR, Tu EY, et al. Practice patterns and opinions in the treatment of Acanthamoeba keratitis. Cornea. 2011;30:1363-1368.
23. Chew HF, Yildiz EH, Hammersmith KM, et al. Clinical outcomes and prognostic factors associated with Acanthamoeba keratitis. Cornea. 2011;30:435-441.
24. Sun X, Zhang Y, Li R, et al. Acanthamoeba keratitis: Clinical characteristics and management. Ophthalmology. 2006;113:412-416.
25. Bang S, Edell E, Eghrari AO, et al. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. Am J Ophthalmol. 2010;149:66-69.
26. Bacon AS, Frazer DG, Dart JK, et al. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye (Lond). 1993;7(pt 6):719-725.
27. Clarke DW, Niederkorn JY. The pathophysiology of Acanthamoeba keratitis. Trends Parasitol. 2006;22:175-180.
28. Gopinathan U, Garg P, Fernandes M, et al. The epidemiological features and laboratory results of fungal keratitis: A 10-year review at a referral eye care center in South India. Cornea. 2002;21:555-559.
29. Bharathi MJ, Ramakrishnan R, Meenakshi R, et al. Microbial keratitis in South India: Influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007;14:61-69.
30. Yamazoe K, Yamamoto Y, Shimazaki-Den S, et al. Visual outcome in Japanese patients with Acanthamoeba keratitis. Eye (Lond). 2012;26:517-522.
31. Fydryszewski NA, Hanna PH. Acanthamoeba keratitis-A diagnostic challenge. Clin Lab Sci. 2011;24:202-207.
32. Bacon AS, Dart JK, Ficker LA, et al. Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology. 1993;100:1238-1243.
33. Chalmers RL, Wagner H, Mitchell GL, et al. Age and other risk factors for corneal infiltrative and inflammatory events in young soft contact lens wearers from the Contact Lens Assessment in Youth (CLAY) study. Invest Ophthalmol Vis Sci. 2011;52:6690-6696.
34. A 2011 AOA American Eye-Q(r) Survey Shows Generations Don't See 'Eye to Eye.' AOA, 13 October 2013. Available at: Http://newsfromaoa.org/ 2011/10/13/2011-Aoa-American-eye-q-survey-shows-generations-don'tsee-' eye-To-eye. Accessed October 23, 2013.
35. van der Meulen IJ, van Rooij J, Nieuwendaal CP, et al. Age-related risk factors, culture outcomes, and prognosis in patients admitted with infectious keratitis to two Dutch tertiary referral centers. Cornea. 2008;27:539-544.
36. Butler TK, Spencer NA, Chan CC, et al. Infective keratitis in older patients: A 4 year review, 1998-2002. Br J Ophthalmol. 2005;89:591-596.
37. McClellan K, Howard K, Niederkorn JY, et al. Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci. 2001;42:2885-2893.
38. Park DH, Palay DA, Daya SM, et al. The role of topical corticosteroids in the management of Acanthamoeba keratitis. Cornea. 1997;16:277-283.
39. Dart JK, Radford CF, Minassian D, et al. Risk factors for microbial keratitis with contemporary contact lenses: A case-control study. Ophthalmology. 2008;115:1647-1654.